¤@¦Ê¹s¤@¦~«×¤º¬ì±M¬ìÂå®v¦Ò¸Õµ§¸ÕÃD -- ·P¬V¬ì

(D) 1. ¥H¤U¦³Ãöµo¿N©M¥Ö¯lªº±Ô­z¡A¦óªÌ¥¿½T¡H (1)¤G´Á±ö¬rªº¥Ö¯l³Ì±`¥X²{¦b¤â´x¤ß©M¸}©³ (2)©}¤½¯f¡]Chikungunya fever¡^³Ì±`¨£¥Ö¯l¦b¤WªÏ©MÁy³¡¡A±`¦ñÀH¤pÃö¸`¯kµh (3)µn­²¼ö¬ù50%·|¦³¥Ö¯l¡A±`¥ÑÂß·F¶}©l¡AÄ~¦Ó´²¦ÜªÏÅé©MÁy³¡ (4)®~Âίfªº¥Ö¯l±`¥ÑªÏºÝ¶}©l¡A¦Ó«áÂX¤ÎÂß·F©MÁy³¡ (5)³Â¯lªº¥Ö¯l±`¥ÑÁy³¡©¹¤UÂX®i¡A³Ì²×¨ì¤â´x¤ß©M¸}´x¤ß
A.(1)+(2)+(3)+(4)
B.(1)+(2)+(3)+(5)
C.(1)+(2)+(4)+(5)
D.(1)+(2)+(3)
E.(1)+(3)+(4)
 
(E) 2. ¤@¦W¨k¤l¦b¤j³°¤u§@®É¦]¥~¥X¾D³¥¤ü«r¶Ë¸}³k¡A·í®É¥¼´NÂå¡A¤@­Ó¦h¤ë«á¥X²{¤U¥b¨­²§±`Äo¡B³Âµh¡B¹Ã¦R¡B§]Ã`§xÃø¤Î³ïÄV¸~µhµ¥¯gª¬¡A¨Ã¦³®£¤ô¤§²{¶H¡A´NÂå«á¦]ºÃ¦ü¨g¤ü¯f(rabies) ¦Ó¤J°|¡AÃö©ó¦¹¯f¡A½Ð°Ý¥H¤U´y­z¦óªÌ¿ù»~¡H
A.¯f±w®£¤ô¤§²{¶H¬O¦]«|³ï³¡¦Ù¦×¤§µjÅË©Ò¤Þ°_¡C
B.¥xÆW¦Û¥Á°ê¥|¤Q¤K¦~°_¥xÆW¦a°Ï§Y¤£¦A¦³¤Hªº¥»¤g¯f¨Ò¡A¥Á°ê¤­¤Q¦~¤@¤ë«á§Y¥¼¦A¥X²{°Êª«ªº¯f¨Ò¡C¥Ø«e¦b¥xÆW³Q¥»¦aªºª¯¡B¿ß«r¶Ë¡A­ì«h¤W¤£¥²¬I¥´¤H¥Î¨g¤ü¯f§K¬Ì²y³J¥Õ©Î¬Ì­]¡C
C.¦p»Ý«e©¹¨g¤ü¯f¬Ì°Ï¡A«Øij¦æ«e¦Ü¤Ö¤@­Ó¤ë¡A±µºØ¤T¾¯¬Ì­]¥H²£¥Í§K¬Ì«OÅ@¡C
D.¦b¬Ì°Ï³Q°Êª««r¶Ë«á¡A©y¹ý©³¦a²M¬~¡B®ø¬r¶Ë¤f¡A¨³³t±µ¨ü¤H¥Î¨g¤ü¯f§K¬Ì²y³J¥Õ¤Î±µºØ4¾¯¬Ì­]¡C
E.­Y¥¼ªvÀø¡A¦¹¯f­P¦º²v¬ù¬°45%¡C
 
(D) 3. ¤ý¤j©ú¬O¤@¦ì20·³ªº¤j¾Ç¤G¦~¯Å¾Ç¥Í¡A¥Ñ©ó¥L¬O¦b®Õ¶é¤º¤@¦ì¶Ç¬V©Êµ²®Ö¯f¤H(­@»Ä©Ù¤ù¶§©Ê¥Bµ²®Öµß°ö¾i¶§©Ê)ªº±K¤Á±µÄ²ªÌ¡A¬Y¤é¥L®³µÛ¤½¦@½Ã¥ÍªºÂश³æ¥B¥]§tµ²®Öµß¯À´úÅçµ²ªG¬°20 mm¨Ó¨ì§Aªºªù¶E¡A¸ß°Ý§A¦³Ãöµ²®Ö¯f©M¼ç¥ñ·P¬V(latent tuberculosis infection)ªº°ÝÃD¡C¤U¦C²Õ¦X¦óªÌ¥¿½T¡H (1)³o¦ì¦P¾Çªºµ²®Öµß¯À´úÅçµ²ªG¬°¶§©Ê¡A¥i¥H»{¬°¥L´N¬Oµ²®Ö¯fµo¯f­Ó®×¡A¤]·|¶Ç¬Vµ¹¨ä¥L¤H¡C (2)¥X¥Í®Éªº¥d¤¶­]±µºØ¤@©w·|Åý³o¦ì¦P¾Çªºµ²®Öµß¯À´úÅçµ²ªG§e²{°°¶§©Ê¡A©Ò¥H¤£¥Î¾á¤ßµ²®Ö¯fµo¯f­·ÀI¡C (3)Àu¥ý¶i¦æ¯f¥v¸ß°Ý¬O§_¦³ºC©Ê«y¹Â¶W¹L¤T¶gµ¥¯gª¬¡B²z¾ÇÀˬd©M¯Ý³¡X¥ú¨Óµû¦ô¬O§_¬°¬¡°Ê©Êµ²®Ö¯f¯f¤H¡C (4)°²³]¤ý¦P¾Ç¨S¦³¯gª¬¥B¯Ý³¡X¥ú¥¿±`¡A¥i¨Ï¥Îisoniazid 300 mg ªvÀø9­Ó¤ë¥H´î¤Öµo¯f­·ÀI¡A¬O¥Ø«e¹ï©ó¼ç¥ñ·P¬VªvÀøªº«Øij¡C (5)½Ã±Ð³o¦ì¦P¾Ç±µÄ²ªÌµo¯fªº­·ÀI©M¤@¦ý¥X²{µ²®Ö¯f¬ÛÃö¯gª¬¡AºÉ³t´NÂå¨ÃÀ³´£¿ôÂå®v´¿¬°±µÄ²ªÌ¡C
A.(1)+(3)
B.(2)
C.(3)+(4)
D.(3)+(4)+(5)
E.(4)+(5)
 
(A) 4. ¦h­«§ÜÃĩʵ²®Ö¯f(multidrug-resistant tuberculosis, MDRTB)¬O¥Ø«e¥þ²yµ²®Ö¯f¨¾ªvªº­«¤j¬D¾Ô¡C¤U¦C²Õ¦X¦óªÌ¬°¬O¡H (1)¥xÆWªº¦h­«§ÜÃĩʵ²®ÖºÊ´úµo²{¡G¦bµ²®Ö¯f·s¯f¤H¬°1%¡A¦Aªv¯f¤H(¥]§t´_µo¡BªvÀø¥¢±Ñ©M¥¢¸¨)¬°6-8%¡C¬Û¸û©ó©PÃ䪺¤¤°ê¤j³°(¤À§O¬°5.7%©M25.6%)¤ÎªF«n¨È¡A¥xÆW¬Ì±¡¸û»´·L¡C (2)¦h­«§ÜÃĩʵ²®Öªº¹êÅç«ÇÀˬd¥u¯à¨Ì¿à¶Ç²ÎÃĪ«±Ó·P©Ê¸ÕÅçµ²ªG¡A¥Ø«e·sªº¤À¤l§Ö³t¶EÂ_ªº¤èªk¡A¦p¡GHain test ©ÎXpert¡A¤´©|¦bµû¦ô¤¤¡C (3)¤@¯ëµ²®Ö¯fªºªvÀøÀ³¦X¨Ö¦hºØÃĪ«¡B¾¯¶q¨¬°÷¡B¥B¦³¨¬°÷ªºªvÀø´Á¡A¨ÃÄU¯f¤H¥[¤J³£ªv(directly observed therapy) ½T«OªAÃĶ¶±q©Ê¡A¥i´î¤Ö²£¥Í¦h­«§ÜÃĩʵ²®Ö¯fªº­·ÀI¡C (4)¤@¥¹¬°¦h­«§ÜÃĩʵ²®Ö¯f¤H¡AªvÀø»Ý¦Ò¼{¦X¨Ö4ºØ¥H¤Wªº¦³®ÄÃĪ«¡A¦ý¤£¶·©µªøªvÀø¶W¹L·ð³±Âà18­Ó¤ë¡C (5)¦h­«§ÜÃĵ²®Ö¯f¤H¨Ï¥Îªº¤G½uÃĪ«°Æ§@¥Î¤ñ¤@½u§Üµ²®ÖÃĪ«¦h¡A«Øij¯f¤HÂशµ¹¨ã¸gÅ窺¦h­«§ÜÃįf¤H·ÓÅ@¹Î¶¤Âå°|¡C
A.(1)+(3)+(5)
B.(2)+(4)
C.(2)+(3)+(4)
D.(1)+(2)+(5)
E.(1)+(4)+(5)
 
(E) 5. ¦³Ãö¬y·P¬Ì­]±µºØ°Æ§@¥Î»P¸T§Ò¯g¤§±Ô­z¡A¤U¦C¦óªÌ¥¿½T¡H (1)¹ïÂû³JÄY­«¹L±ÓªÌ¬°±µºØ¬y·P¬Ì­]¤§¸T§Ò¡C (2)°£¤F¬ü°ê1976¦~H1N1½Þ¬y·P¬Ì­]¥~¡A±µºØ©u¸`¬y·P¬Ì­]«áµo¥ÍGuillain-Barre syndrome¤§¾÷²v·¥§C¡C (3)¤p©ó6­Ó¤ë¤§À¦¨à¤£©y±µ¨ü¬y·P¬Ì­]¬I¥´¡C (4)³¡¤À¬y·P¬Ì­]¤¤§t¦³¥Ò°ò¨E»P¤A°ò¨E¥Î¥H«O¦s¬Ì­]¡A¥Ò°ò¨E»P¤A°ò¨E§¡¥i¬°¤HÅé©Ò¥NÁ¡C (5)¦b§PÂ_¬y·P¬Ì­]±µºØ«á¤£¨}¨Æ¥ó»P¬Ì­]±µºØ¤§¦]ªGÃö«Y®É¡A¸Ó¤£¨}¨Æ¥ó¤§¦º¤`©Î­«¯g¤ñ²v¬O­«­nªºÆ[¹î«ü¼Ð¡C
A.(1)+(2)+(3)
B.(1)+(2)+(4)
C.(1)+(3)+(4)
D.(1)+(3)+(5)
E.(1)+(2)+(3)+(5)
 
(E) 6. Ãö©ó¦è¥§Ã¹¼ö¡]West Nile Fever¡^¤Î©}¤½¼ö¡]Chikungunya fever¡^¡A¥H¤U¦óªÌ¬O¥¿½Tªº¡H
A.¦¹¨âºØ¯e¯f¥i¸g¥Ñ¯f´C°A¥m«r¶Ç¬Vµ¹¤HÃþ¡C®È¹C¨¾°A¥i¿ï¾Ü§t¼ÄÁ×(DEET)ªº¨¾°A²£«~¡A®ÄªG³Ì¦n¡C
B.³¾Ãþ¬O¦è¥§Ã¹¯f¬r©ó¦ÛµM¬É¥D­n±J¥D¡C
C.¥i¯à¶Ç¼½¦è¥§Ã¹¼ö¤Î©}¤½¼öªº¯f´C°A¡A¤]¤j¶q¤À§G©ó¥xÆW¡C
D.®È«È¦Û¦è¥§Ã¹¯f¬r¬y¦æ°ÏÂ÷¹Ò¦^¥x¤@­Ó¤ë¤º¡AÀ³¼È½w®½¦å¡A¥H¨¾½d¿é¦å¶Ç¬V¦è¥§Ã¹¯f¬r¡C
E.¥H¤W¬Ò¥¿½T
 
(E) 7. ªñ¦~¤¤°ê¤j³°¦bªe«n¡B¤sªF¡B´ò¥_¡B¦wÀ²¡B¦¿Ä¬©M¿ñ¹ç¬Ù³Qµo²{¾É­P¡uµo¿N¦ñ¦å¤pªO´î¤Ö¯g­Ô¸s¡]severe fever with thrombocytopenia syndrome¡^¡v¡A¦³Ãö±Ô­z¦óªÌ¥¿½T¡H
A.­P¯f­ìÄݩ󥬥§¨È¯f¬r¬ì¡]Bunyaviridae¡^¡C
B.¦¹¯f¬rªº¶Ç¼½¼Ò¦¡¥i³z¹Lãë¡]tick¡^ªº¥m«r¡C
C.¶Ç¼½¥ç¥i³z¹Lª½±µ±µÄ²±wªÌªº¦å²G©Î§t¦å¤Àªcª«¡C
D.±wªÌ¥H¾·~¹A¥Á¬°¥D¡A¦º¤`²v¹F10%¥H¤W¡C
E.¥H¤W¬Ò¥¿½T¡C
 
(E) 8. ·R´þ¯f¬r¡]HIV¡^¶Ç¼½¤§­·ÀI¡A¤U¦C±Ô­z¦óªÌ¬°¬O¡H
A.¥Ñ©óª½¸zÂH½¤ªº¸Ñ­åµ²ºc«ÜÁ¡¡A¨ã©ö¨ü¶Ë¤§¯S©Ê¡A¥¼±Ä«OÅ@±¹¬Iªº¨k©Ê©Î¤k©Ê¨zªù©Ê¥æ±µ¨üªÌ¡A¨ä·P¬VHIV¤§­·ÀI³Ì°ª¡C
B.¥¼±Ä«OÅ@¤§³±¹D©Ê¥æ±µ¨üªÌ¡A¥ç¬O·P¬VHIV¤§°ª¦MÀIªÌ¡C
C.·í¦³¥Í´Þ¾¹©x©Ê¯f¡B²£¥Í§¿¹Dª¢¡B°Æ¸Aª¢©Î¼ìºÅµ¥±¡ªp¡A¥Ñ©óµoª¢³¡¦ì·|¨Ï²O¤Ú²y©M³æ®Ö²y¼Æ¥Ø¼W¥[¡A·|¼W¥[ºë²G¤¤ªºHIV¯f¬r¶q¡C
D.¶Ç¼½HIV¾÷²v³Ì°ªªº®É¾÷¬OHIV¦­´Á·P¬V¤ÎHIV¥½´Á·P¬V¡C
E.¥H¤W¬Ò¥¿½T
 
(D) 9. ¦³Ãöµ²®Öµß(Mycobacterium tuberculosis)·P¬V¤§³¯­z¡A¤U¦C±Ô­z¦óªÌ¿ù»~¡H
A.µ²®Öµß·P¬VªÌ²×¨ä¤@¥Íµo¯fªº¾÷·|¬ù¬°10%¡C
B.ªì¦¸·P¬Vµ²®Öµß«á¡A¥H·P¬V«á«e¤@¦~µo¯fªº¥i¯à¾÷·|³Ì°ª¡C
C.¨å«¬¤§µ²®Öµß²O¤Ú¸¢ª¢¯gª¬¬°µLµh©Ê(painless)ÀV«á²O¤Ú¸¢ª¢©ÎÂê°©¤W²O¤Ú¸¢ª¢¡C
D.µ²®Ö¯f±wªÌ§Y¨Ï¦b§¹¦¨ªvÀø«á¡A¤´¦³¬ù50%±wªÌ²O¤Úµ²¦³µ²®Öµß¼ç¥ñ¡A¤£©ö®Úªv¡A´_µo¾÷²v°ª¡C
E.µ²®Öµß·ð©Ù¤ù¶§©Êµo¯f¤§±wªÌ¡A­Y¥¼±µ¨üªvÀø¡A5¦~¤ºªº¦º¤`²v¬ù¬°65%¡C
 
(A) 10. ¬Î½H(scabies)¬O±`µo¥Í©ó¦w¾i¤¤¤ß©Îºë¯«ÂåÀø°|©Òªº¶Ç¬V©Ê¯e¯f¡A¤U¦C±Ô­z¦óªÌ¥¿½T? (1)Burrow(¦a¹D)±`¦ì©ó¤âµÃ¤º°¼¡B«ü¶¡¤Î¥Í´Þ¾¹(³±²ô)³¡¤À¡C (2)Burrow¤¤¦³»Û©Ê¬ÎÂΡA²Õ´¯f²zÀˬd¥D­n¬°¤¤©Ê¥Õ¦å²y(neutrophil)¤§®û¼í¡C (3)®¿«Â«¬¬Î½H(Norwegian scabies)¦nµo©ó§K¬Ì¤£¥þ¯f±w¡A¬ÎÂμƶq¤£¦h¡AªvÀø®e©ö¡C (4)·P¬V¬ÎÂΫá¦Üµo¯f¯gª¬¥X²{¤§¼ç¥ñ´Á¥iªø¹F6¶g¡C (5)§K¬Ì¥¿±`ªº±Ú¸s·P¬V¬ÎÂΪº¼Æ¶q¬ù¦b¨C¤H15°¦¥H¤U¡C
A.(1)+(4)+(5)
B.(1)+(2)+(4)
C.(2)+(3)+(5)
D.(2)+(3)+(4)
E.(2)+(4)+(5)
 
(B) 11. 19·³¨k©Ê¦b¥xÆWµn¤s®È¹C«á¶}©l¥X²{µo¿N¡BÀYµh¡B¥þ¨­¦Ù¦×»Äµh¡A©óªù¶E®Éµo²{¯f¤H¥k»L¤º°¼¦³¤@µJ¯m(eschar)¡A¥B¹«ÁѲO¤Ú¸¢¸~¤j¡A¦å²GÀˬd¥Õ¦å²y¼Æ¬°3150/£gL¡BGOT 112 IU/L¡BGPT184 IU/L¡A¹ï©ó¦¹¯f¨Ò¤§¤U¦C±Ô­z¦óªÌ¿ù»~?
A.¦¹¯e¯f¬°®~Âίfscrub typhus¡A­P¯fµß¬°Orientia tsutsugamushi
B.¦¹­P¯fµß¬O¥Ñ½¾(louse)©Ò¶Ç¼½
C.¥xÆW¬y¦æ¦¹·P¬Vªº¦a°Ï¦bªF³¡¦a°Ï¤ÎÂ÷®q
D.ªvÀøªº­º¿ïÃĪ«¬Odoxycycline
E.¦¹¯f¤§¼ç¥ñ´Á(incubation period)¬ù¬°9¦Ü18¤Ñ
 
(C) 12. ¦³ÃöÄY­«±Ñ¦å¯g®É¯f±w¤§Á{§É³B²z¡A¤U¦C±Ô­z¦óªÌ¿ù»~?
A.¤¤¤ßÀR¯ßÀ£(central venous pressure)À³ºû«ù¦b8-12 cmH2O¡C
B.ÀR¯ß¿é²Gºwª`À³¨Ï¨C¤p®É§¿²G¥Xºû«ù¤j©ó0.5 ml/kgÅé­«¡A¥²­n®É¨Ï¥Î§Q§¿¾¯¡C
C.§C¦åÀ£¥ð§Jµo¥Í®É¡A½wºCµ¹¤©¥Í²z­¹ÆQ¤ô1000 ml¦Ü2000 ml¡Aºwª`®É¶¡ºû«ù¬ù3¤p®É¥HÁקKªÍ¤ô¸~¡C
D.¦¨¤H¦å¬õ¯À§C©ó7 g/dL®É¡A¦X²zªº¿é¦å¥Ø¼ÐÀ³¹F¨ì9 g/dL¥H¤W¡C
E.Bicarbonate ¦b¥NÁ©ʻĤ¤¬r(°Ê¯ß¦åpH<7.2)¥i¦Ò¼{µ¹¤©¡A¦ý¥Ø«e¤´¯Ê¥F¥i§ïµ½¦å´`°Ê¤O(hemodynamics)ªº¹êÃÒ¡C
 
(D) 13. ¤@¦ì35·³¨k©Ê¯f¤H¡A¦]µo¿N¬È´H2¤Ñ¦Ü«æ¶E´NÂå¡A²z¾ÇÀˬdµo²{¤âµÃ¦³³\¦h¹L¥hª`®g°w¤Õªº¶Ë¤f¡A¤ßŦť¶E¦³©úÅ㦬ÁY¤ßÂø­µ¡A¤ßŦ¶W­µªiµo²{¤T¦yä¤W¦³Âإͪ«(vegetation)¡A¦å²G°ö¾i2®M§¡¬°¬°­²Äõ¤ó³±©Êµß¡A½Ð°Ý¤U¦C¦óªÌ¬O³Ì¦³¥i¯àªº­P¯fµß?
A.Staphylococcus aureus(ª÷¶À¦â¸²µå²yµß)
B.Klebsiella pneumoniae(§J¹p¬f¤ó±ìµß)
C.Listeria monocytogenes(§õ´µ¯Sµß)
D.Pseudomonas aeruginosa(ºñÁw±ìµß)
E.Acinetobacter baumannii(Àj°Ò¤£°Ê±ìµß)
 
(D) 14. ¤U¦C¦³Ãö¤ÆÁw©Ê¨xÁwºÅ¤§±Ô­z¡A¦óªÌ¿ù»~¡H
A.¥xÆW¦a°Ï­ìµo©Ê¤ÆÁw©Ê¨xÁwºÅ­P¯fµß¥HKlebsiella pneumoniae³Ì±`¨£
B.¥xÆW¦a°Ï­ìµo©Ê¤ÆÁw©Ê¨xÁwºÅ¯f±w±`¦³¿}§¿¯f©Î³¤°s¯f¥v
C.¤ÆÁw©Ê¨xÁwºÅ­P¯f­ì¥i¯à¦å´`Âಾ¦Ü¸£³¡¡B°©Àfµ¥³B
D.¦å²G¥Í¤ÆÀˬd¥H¨xÂà´«úCALT¡BAST¬ù¦³70%±wªÌ¤É°ª³Ì¬°±`¨£
E.§Ü¥Í¯À¥[¤W¸g¥Ö¾ÉºÞ¤Þ¬y¬°¦³®ÄªvÀø¤èªk
 
(E) 15. ¦³ÃöÂåÀø·ÓÅ@·P¬V¯f­ì¤§¶Ç¼½³~®|¡A¤U¦C°t¹ï¦óªÌ¿ù»~?
A.¦h­«§ÜÃĩʵßAcinetobacter baumannii - ±µÄ²¦Ã¬VªºÅ¥¶E¾¹©Î¦åÀ£­p
B.B«¬¤ÎC«¬¨xª¢¯f¬r - ·P¬VªÌ¦åºÞ¾ÉºÞ¯d¸m°wÀY¥Ö½§°w¤ã
C.Legionella pneumophila(°h¥î­x¤Hµß) - ¦Ã¬Vªº¤ô·½©Î®ðÃú§l¤J
D.Group A Streptococcus(A«¬Ãì²yµß) - ±´³XªÌ¡B·ÓÅUªÌ¤§«y¹Â­¸ªj
E.Aspergillus fumigatus(¯uµß) - ¦Ã¬VªºÂåÀø¤H­û¤â±µÄ²¶Ç¬V
 
(C) 16. ¤@¦ì70·³¨k©Ê±wªÌ¡A¦]¸£¤¤­·±`¯d¸m§¿²G¾ÉºÞ(Foley catheter)¡A¦]¦å§¿¤Îµo¿N¤T¤Ñ¦Ü¥»°|«æ¶E¡A¨â®M¦å²G°ö¾i§¡ªø¥XEnterococcus faecalis¡A­Y¹ï§Ü¥Í¯À¬Ò¨ã¦³·P¨ü©Ê®É(susceptible)¡A¦¹®É¤U¦C¦óºØÃĪ«ªvÀø¬O³Ì¨Î¦Ò¼{­º¿ï?
A.Oxacillin + gentamicin
B.Ceftriaxone (3rd generation cephalosporin)
C.Ampicillin + gentamicin
D.Cefazolin + gentamicin (1st generation cephalosporin)
E.Vancomycin
 
(E) 17. ¤@¦ì29·³Ãh¥¥°ü¤k¡A¦]µo¿N¦í°|»Ý¨Ï¥Î§Ü·L¥Íª«»s¾¯¡A½Ð°Ý¤U¦C§Ü·L¥Íª«»s¾¯¦óªÌ¬OÄÝ©óÃh¥¥ÃĪ«¦w¥þ¤ÀÃþClass C©ÎD¯ÅÃĪ«¡AÀ³ÁקK¨Ï¥Î? (1)Erythromycin estolate (2)Metronidazole (3)Meropenem (4)Clarithromycin (5)Gentamicin
A.(1)+(5)
B.(2)+(3)
C.(2)+(5)
D.(3)+(4)
E.(4)+(5)
 
(A) 18. 18·³¤k©Ê¡A¬ðµMµo¿N¡BÀYµh¤Î¹Ã¦R¡A¦í°|«á²z¾ÇÀˬdµo²{¯f¤H¶ÝºÎ¤ÎÀV³¡»øµw¡A¥|ªÏ¥i¨£¦h³Bµµ´³¥X¦å¯l¡B¦å²G¥Õ¦å²y¬°18000/£gl¡A¸£¯áÅè²GÀˬdµo²{¥Õ¦å²y1100/£gl¡Aneutrophil¦û92¢H¡A¸²µå¿}11 mg/dl¡C¥H¤U¦óªÌ¬O³Ì¥i¯àªº­P¯f­ì?
A.Neisseria meningitidis
B.Enterovirus type 71
C.Haemophilus influenzae
D.Listeria monocytogenes
E.Herpes simplex virus
 
(E) 19. ¤U¦C¦³ÃöVaricella-zoster virus ¯f¬r·P¬Vªº±Ô­z¡A¦óªÌ¥¿½T?
A.¦¹¯f¬r¬°ÂùªÑRNA¯f¬r¡Aªì¦¸·P¬V³~®|¥D­n¬°©I§l¹D¶Ç¼½
B.ªì¦¸·P¬V«á¼ç¥ñ¦b¯áÅ踡®Ú¯«¸g(ventral root ganglia)¡A©ö´_µo©ó¯Ý´Õ¦Ü¸y´Õ¥Ö¸`
C.¥Ø«e©|µL¾A·íªº¬Ì­]¥i¥Î©ó¹w¨¾Varicella zoster virus¤§·P¬V
D.¸£ª¢µo¥Í®É®e©ö¦³§½³¡¥X¦å©ÊÃa¦º¡A»PHerpes simplex virus¸£ª¢Á{§Éªí²{Ãþ¦ü¡A¦º¤`²v°ª
E.Ramsay-Hunt syndrome¥i¦b¥~¦Õ¹D¨£¨ì¤ôªw¡A¦ÞÀY«e¤T¤À¤§¤G¥¢¥h¨ýı
 


< ¤@¦Ê¹s¤@¦~«×¸ÕÃD¥Ø¿ý >